Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision line now shows Revision: v3.6.6, indicating a minor update to the page's version. This update replaces the previous revision tag and does not modify substantive study details.
    Difference
    0.1%
    Check dated 2026-08-29T19:48:16.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision was updated from v3.6.4 to v3.6.5, reflecting a platform update without changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T22:24:10.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, reflecting a newer platform release. This does not alter the study information displayed.
    Difference
    0.1%
    Check dated 2026-07-25T12:56:11.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new version of the page content. This reflects a minor update to the site's documentation or presentation without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-04T04:13:09.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2, signaling a newer version of the page content has been published.
    Difference
    0.1%
    Check dated 2026-06-27T02:19:56.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Recruitment status now indicates no longer looking for participants, clarifying enrollment availability. The page adds new user guidance sections and adjusts the Intervention/Treatment heading formatting, along with a version note.
    Difference
    0.5%
    Check dated 2026-06-12T16:32:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.